Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat

…, T Horie, T Suzuki, T Ishikawa, M Tsutsui…

Index: Narimatsu, Shizuo; Arai, Takayuki; Watanabe, Toshiyuki; Masubuchi, Yasuhiro; Horie, Toshiharu; Suzuki, Tokuji; Ishikawa, Tsutomu; Tsutsui, Michio; Kumagai, Yoshito; Cho, Arthur K. Chemical Research in Toxicology, 1997 , vol. 10, # 3 p. 289 - 295

Full Text: HTML

Citation Number: 25

Abstract

Repeated administration of propranolol (PL) to rats causes the inhibition of cytochrome P450-2D (P450-2D) enzyme. We recently found that 4-hydroxypropranolol (4-OH-PL) was biotransformed to 1, 4-naphthoquinone (1, 4-NQ) by superoxide (SO) anions in medium containing rat liver microsomes and NADPH and proposed that the binding of the quinone to P450-2D apoproteins might be one of mechanisms for the enzyme inhibition [Narimatsu et ...

Related Articles:

Ring-hydroxylated propranolol: synthesis and. beta.-receptor antagonist and vasodilating activities of the seven isomers

[Oatis Jr.; Russell; Knapp; Walle Journal of Medicinal Chemistry, 1981 , vol. 24, # 3 p. 309 - 314]

A new standardized electrochemical array for drug metabolic profiling with human cytochromes P450

[Fantuzzi, Andrea; Mak, Lok Hang; Capria, Ennio; Dodhia, Vikash; Panicco, Paola; Collins, Stephen; Gilardi, Gianfranco Analytical Chemistry, 2011 , vol. 83, # 10 p. 3831 - 3839]

Ring-hydroxylated propranolol: synthesis and. beta.-receptor antagonist and vasodilating activities of the seven isomers

[Oatis Jr.; Russell; Knapp; Walle Journal of Medicinal Chemistry, 1981 , vol. 24, # 3 p. 309 - 314]

. beta.-Adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols

[Crowther,A.F.; Smith,L.H. Journal of Medicinal Chemistry, 1968 , vol. 11, # 5 p. 1009 - 1013]

Product inhibition and dose??dependent bioavailability of propranolol in the isolated perfused rat liver preparation

[Ghabrial; Nand; Stead; Smallwood; Morgan Journal of Pharmaceutical Sciences, 1994 , vol. 83, # 7 p. 931 - 936]

More Articles...